Shares of Humana and WellPoint are falling in Wednesday's trading after both health insurers reported lower second-quarter profit, despite significant revenue growth. Humana reported net income that fell 18% to $344 million, or $2.19 a share, in line with analyst estimates. The company attributed the decline to investments in the exchanges created under healthcare reform, as well as drug costs. However, Bank of America Merrill Lynch analyst Kevin Fischbeck said Humana's results actually beat his estimate by 36 cents a share. WellPoint's ajusted earnings came to $2.44 a share, topping analyst expectations of $2.26 a share. J.P. Morgan analyst Justin Lake, who has a Neutral rating on WellPoint, said the company's commercial operating earnings and government outperformed his estimates.

More from Video

Jim Cramer's Investing Rule 12: Cash Is for Winners

Jim Cramer's Investing Rule 12: Cash Is for Winners

Video: Here's Where to Put Your Money Amid Trade War Fears

Video: Here's Where to Put Your Money Amid Trade War Fears

Ford's CEO Just Got a Badly Needed Vote of Confidence From His Boss

Ford's CEO Just Got a Badly Needed Vote of Confidence From His Boss

60 Seconds: What Are the Bank Stress Tests?

60 Seconds: What Are the Bank Stress Tests?

Chart Professor: 3 Things You Need to Know About Every Stock Chart

Chart Professor: 3 Things You Need to Know About Every Stock Chart